Infectious Diseases 1106 - Infectious Disease Alert - Jun 01, 2007

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Associate Editor
Jessica C. Song, MA, PharmD
Pharmacy Residency Coordinator
Assistant Professor
Pharmacy Practice
University of the Pacific
Stockton, CA
Pharmacy Clerkship and Coordinator
Santa Clara Valley Medical Center
Section Editor
Managed Care

Author
Paul Hsiao, PharmD
Pharmacist Specialist
Santa Clara Valley Medical Center

Subjects:

  • Shaking Things Up: The New Guidelines for Antibiotic Prophylaxis of Endocarditis
  • Acute Hepatitis in the U.S. —A Success Story, But the Game Isn't Over
  • Varicella-Zoster Virus Vaccine (Zostavax)
  • The California Encephalitis Project — 1998-2005
  • Updates

Objectives:

  • To discuss the diagnosis and treatment of infectious diseases
  • To present current data regarding use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • To present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • To discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapy

Financial Disclosure:

Infectious Disease Alert’s Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Peer Reviewer, Connie Price, MD, reports no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company related to this field of study.

Updates Author, Carol A. Kemper, MD, FACP, Associate Editor, Jessica C. Song, MA., PharmD, and Author, Paul Hsiao, PharmD, reports no financial relationships relevant to this field of study.

Copyright 2007 AHC Media. All rights reserved.